60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
60 Degrees Pharmaceuticals, Inc. (SXTP) is a Biotechnology company based in US with a market capitalization of $1.3M. Revenue grew 65.5% year-over-year and free cash flow was negative at -$7.1M. This page tracks SXTP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 3 employees · IPO Jul 12, 2023
Valuation
Valuation & price
$1.39as of May 17, 2026· -80.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.37
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.3M
Market cap
65.5%
Revenue growth (YoY)
22.3%
Gross margin
-$7.1M
Free cash flow (USD)
-$2.6M
Net debt
Net cash position
489.7%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2020 → 2025
Free cash flow by year
2020 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
1
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-1.28)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 20, 2026Filing
Investor Presentation
- 8-K eventJul 9, 2026Filing
Clinical Trial Update
- Insider buyJun 15, 2026Filing
Insider Buy $10KDOW GEOFFREY S · Director, President and CEO · $10.1K
- 8-K eventJun 3, 2026Filing
Regulatory Application Planned
- 8-K eventMay 18, 2026Filing
Director Appointment
- Quarterly reportMay 15, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is 60 Degrees Pharmaceuticals, Inc.'s market cap?
60 Degrees Pharmaceuticals, Inc. (SXTP) has a market capitalization of $1.3M.
What is SXTP's P/E ratio?
A meaningful P/E ratio is not available for SXTP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SXTP's price-to-book (P/B) ratio?
SXTP trades at 0.37 times book value per share.
When did 60 Degrees Pharmaceuticals, Inc. last report earnings?
SXTP last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying SXTP stock?
Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at 60 Degrees Pharmaceuticals, Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.